MELONI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 7.396
AS - Asia 5.456
EU - Europa 4.922
SA - Sud America 702
AF - Africa 179
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 7
Totale 18.673
Nazione #
US - Stati Uniti d'America 7.194
CN - Cina 2.555
SG - Singapore 1.271
IE - Irlanda 1.048
DE - Germania 644
HK - Hong Kong 581
FI - Finlandia 569
UA - Ucraina 558
BR - Brasile 557
RU - Federazione Russa 525
VN - Vietnam 479
IT - Italia 454
FR - Francia 304
SE - Svezia 286
GB - Regno Unito 257
IN - India 129
CA - Canada 109
ZA - Sudafrica 104
JP - Giappone 69
BD - Bangladesh 62
MX - Messico 57
IQ - Iraq 56
AR - Argentina 53
PL - Polonia 50
TR - Turchia 40
ES - Italia 38
BE - Belgio 33
NL - Olanda 30
EC - Ecuador 26
AT - Austria 25
ID - Indonesia 25
PK - Pakistan 25
CZ - Repubblica Ceca 23
SA - Arabia Saudita 20
UZ - Uzbekistan 20
CO - Colombia 17
VE - Venezuela 16
CL - Cile 15
PH - Filippine 15
MY - Malesia 14
MA - Marocco 13
AZ - Azerbaigian 12
IR - Iran 12
LT - Lituania 12
AE - Emirati Arabi Uniti 11
PY - Paraguay 11
TN - Tunisia 10
AL - Albania 9
KE - Kenya 9
EG - Egitto 8
EU - Europa 7
JM - Giamaica 7
LV - Lettonia 7
NP - Nepal 7
RO - Romania 7
DZ - Algeria 6
KZ - Kazakistan 6
MU - Mauritius 6
PA - Panama 6
PT - Portogallo 6
RS - Serbia 6
AU - Australia 5
DO - Repubblica Dominicana 5
GR - Grecia 5
AO - Angola 4
CH - Svizzera 4
CR - Costa Rica 4
DK - Danimarca 4
HU - Ungheria 4
IL - Israele 4
JO - Giordania 4
KG - Kirghizistan 4
SN - Senegal 4
TH - Thailandia 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
ET - Etiopia 3
HN - Honduras 3
KR - Corea 3
KW - Kuwait 3
MN - Mongolia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DM - Dominica 2
EE - Estonia 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
NO - Norvegia 2
QA - Qatar 2
SI - Slovenia 2
TG - Togo 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
Totale 18.648
Città #
Dublin 1.043
Chandler 974
Ashburn 725
Singapore 718
Jacksonville 655
San Jose 616
Dallas 602
Hong Kong 567
Nanjing 483
Beijing 471
Boardman 299
Helsinki 229
Munich 229
Los Angeles 218
Nanchang 177
Princeton 176
Lauterbourg 170
Lawrence 168
New York 167
Wilmington 157
Shenyang 150
Ho Chi Minh City 149
Hebei 142
Changsha 134
Jiaxing 126
Medford 126
Hanoi 112
Moscow 111
Ann Arbor 110
Milan 94
Johannesburg 92
Pavia 92
Shanghai 91
Tianjin 81
Hangzhou 77
Buffalo 75
Turku 69
Redondo Beach 66
Tokyo 64
Orem 56
São Paulo 54
Woodbridge 48
Seattle 46
Warsaw 44
London 42
Verona 42
The Dalles 40
Santa Clara 37
Toronto 37
Council Bluffs 36
Montreal 35
Brooklyn 34
Washington 33
Brussels 31
Houston 28
Norwalk 28
Chennai 27
Da Nang 26
Frankfurt am Main 26
Atlanta 25
Haiphong 25
Stockholm 25
Rio de Janeiro 24
San Francisco 24
Columbus 23
Denver 23
Baghdad 22
Chicago 22
Falkenstein 22
Zhengzhou 22
Kunming 21
Boston 19
Mexico City 19
Phoenix 19
Biên Hòa 18
Poplar 18
Vienna 18
Paris 17
Pune 17
Tashkent 17
Des Moines 16
Nuremberg 16
Piscataway 15
Manchester 14
Amsterdam 13
Belo Horizonte 13
Fairfield 13
Jinan 13
Guangzhou 12
Baku 11
Curitiba 11
Mumbai 11
Ninh Bình 11
Ottawa 11
Porto Alegre 11
Taizhou 11
Istanbul 10
Ningbo 10
Secaucus 10
Brno 9
Totale 12.236
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 260
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 174
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 167
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 160
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 159
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation 157
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 156
Fotoaferesi extracorporea nel trattamento del rigetto polmonare cronico: risultati clinici ed immunologici preliminari di una piccola coorte di pazienti sottoposti a trapianto di polmone. 154
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 152
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 151
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
Bronchoalveolar Lavage Fluid Proteome in Bronchiolitis Obliterans Syndrome: Possible Role for Surfactant Protein A in Disease Onset 148
A mid-term follow-up with a lung ultrasonographic score correlates with the severity of COVID-19 acute phase 146
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 146
(1)H NMR To Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification. 143
Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients. 142
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 138
Broncho-alveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to the onset of bronchiolitis obliterans syndrome 138
Indoleamine 2,3-dioxygenase in lung allograft tolerance. 138
Regulatory T cells in kidney transplant recipients. 137
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 136
Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients 136
Minute pulmonary meningothelial-like nodules in the transbronchial biopsy of a lung transplant recipient 134
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 134
Effetti clinici ed immunologici di un trattamento a lungo termine con azitromicina nella sindrome da bronchiolite obliterante dopo trapianto polmonare. 131
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 130
Specific Anti-CMV Reactivity in BAL: A Useful Tool 130
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. 130
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin 130
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 130
The frequency of Interleukin-10 and Interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted Lung 128
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 128
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 127
Aortic valve replacement performed twice through ministernotomy 15 years after lung transplantation. 127
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 127
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 126
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 126
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 125
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 125
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T 124
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 123
Experience with Cylex Immune Cell Function Assay in Clinical Immune Monitoring of Lung Transplant Recipients 122
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 122
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? 121
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 121
Incidence of de novo malignancies in lung transplant recipients in Italy: a sinle institution experience, 1991-2008. 120
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 118
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 118
Alterazione del bilancio Th1/Th2 nei pazienti in trattamento emodialitico: effetto di differenti membrane 117
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. 117
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 117
An innovative cellular approach to BOS: targeted antibody-engineered gold nanoparticles and characterization of cells for new therapeutic treatment 116
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 115
Activity of Th1/Th2 lymphocytes in primary and HCV-related mesangiocapillary glomerulonephritis. 115
Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients 114
Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation 113
Cerebrospinal fluid ferritin in human disease. 113
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 112
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 112
Intermittent hemodiafiltration in refractory congestive heart failure: bnp and balance of inflammatory cytokines 112
Organ Allocation Waiting Time During Extracorporeal Bridge to Lung Transplant Affects Outcomes 110
A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome 109
Rischio di sviluppo di tumori de-novo dopo trapianto di polmone in Italia: esperienza dell'I.R.C.C.S. Policlinico "San Matteo" di Pavia, 1991-2008. 109
Human cytomegalovirus-specific CD4+ and CD8+ T-cells in organ transplant recipiets 109
Persistent human cosavirus infection in lung transplant recipient, Italy. 109
[Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA. 108
CCR4, CCR5, CCR6 expression on BAL lymphocytes and macrophages of patients with bronchiolitis obliterans syndrome. 108
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 106
The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo 106
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 106
Possible Disease Markers in BAL Fluid of BOS Patients 105
Urinary monocyte chemotactic peptide (U/MCP-1) and RANTES (U/RANTES) excretion in human lupus nephritis (SLE/N) 104
Valutazione longitudinale delle cellule treg cd4+cd25highc69- in una coorte di riceventi di trapianto polmonare (ltrs). Un'associazione con il rigetto cronico del trapianto. 104
Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients 103
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop 103
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study 103
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 102
Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles 102
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 100
Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of everolimus 100
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 99
Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study 99
miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p 99
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 98
SORVEGLIANZA DELLE MALATTIE BRONCOPOLMONARI CRONICO-OSTRUTTIVE NELLA POPOLAZIONE DI ROVESCALA (PAVIA) IN RELAZIONE ALL’ ESPOSIZIONE AL FUMO DI TABACCO 98
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 97
CCR4, CCR5, CCR6 expression on BAL lymphocytes and macrophages of patients with bronchiolitis obliterans syndrome 97
Cytokine profile of broncho-alveolar lavage in BOOP and UIP 96
Mechanisms of lung injury in cystic fibrosis. 96
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 96
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation 96
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 96
Role of interleukin18 (IL-18) and interleukin 12 (IL-12) in human lupus nephritis (SLE-N) 95
Caratteristiche cliniche correlate con la diagnosi istologica della bronchiolite obliterante infiammatoria o fibrotica. 95
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 94
Urinary interleukin-18 (IL-18) and monocyte chemotactic peptide-1 (MCP-1) excretion in IGA Nephropathy (IgAN) 94
Different pathways of degradation of SP-A and saturated phosphatidylcholine by alveolar macrophages 94
Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. 93
Serum levels of interleukin12, interleukin 18 and interferon gamma in ischemic acute renal failure (ARF) 93
Totale 12.140
Categoria #
all - tutte 75.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021340 0 0 0 0 0 0 0 0 0 156 143 41
2021/2022754 32 5 18 13 22 20 20 40 50 24 117 393
2022/20232.852 297 206 15 256 290 275 1 163 1.231 21 64 33
2023/20241.302 147 210 59 79 137 341 43 79 8 101 34 64
2024/20253.149 77 210 94 109 87 231 187 282 740 113 353 666
2025/20266.419 546 417 887 732 844 360 1.351 294 604 384 0 0
Totale 18.866